IP Library Granted Patent US 12674147
Granted Patent B2
US 12674147 · App. 17/787,955 · Granted Jul 7, 2026

Chimeric DNA polymerase and application thereof

Inventors: Qun An (Shenzhen, CN); Miaomiao Guo (Shenzhen, CN); Feng Xi (Shenzhen, CN); Fei Guo (Shenzhen, CN); Yue Zheng (Shenzhen, CN); Yuliang Dong (Shenzhen, CN); Wenwei Zhang (Shenzhen, CN)
Assignee: BGI SHENZHEN
C12N9/1252C12P19/34C12Q1/485C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12674147
App. No.
17/787,955
Granted
Jul 7, 2026
Kind
B2
Abstract

A chimeric DNA polymerase includes: a first fragment having at least 80% homology to at least part of an N-end domain of KOD DNA polymerase; a second fragment having at least 80% homology to at least part of an exonucleolytic domain of Pab DNA polymerase; a third fragment having at least 80% homology to at least part of the N-end domain of KOD DNA polymerase; a fourth fragment having at least 80% homology to at least part of a palm domain of Pfu DNA polymerase; a fifth fragment having at least 80% homology to at least part of a finger domain of Pab DNA polymerase; a sixth fragment having at least 80% homology to at least part of the palm domain of Pfu DNA polymerase; and a seventh fragment having at least 80% homology to at least part of a thumb domain of KOD DNA polymerase.

Claims (21)

1 . A chimeric DNA polymerase, comprising:

a first peptide fragment comprising an amino acid sequence of sites 1 to 130 of a KOD DNA polymerase;

a second peptide fragment comprising an amino acid sequence of sites 131 to 337 of a Pab DNA polymerase, an N-terminal end of the second peptide fragment being connected to a C-terminal end of the first peptide fragment;

a third peptide fragment comprising an amino acid sequence of sites 338 to 373 of the KOD DNA polymerase, an N-terminal end of the third peptide fragment being connected to a C-terminal end of the second peptide fragment;

a fourth peptide fragment comprising an amino acid sequence of sites 374 to 448 of a Pfu DNA polymerase, an N-terminal end of the fourth peptide fragment being connected to a C-terminal end of the third peptide fragment;

a fifth peptide fragment comprising an amino acid sequence of sites 449 to 500 of the Pab DNA polymerase, an N-terminal end of the fifth peptide fragment being connected to a C-terminal end of the fourth peptide fragment;

a sixth peptide fragment comprising an amino acid sequence of sites 501 to 591 of the Pfu DNA polymerase, an N-terminal end of the sixth peptide fragment being connected to a C-terminal end of the fifth peptide fragment; and

a seventh peptide fragment comprising an amino acid sequence of sites 591 to 774 of the KOD DNA polymerase, an N-terminal end of the seventh peptide fragment being connected to a C-terminal end of the sixth peptide fragment.

2 . The chimeric DNA polymerase according to claim 1 , wherein the chimeric DNA polymerase has an amino acid sequence set forth as SEQ ID NO: 1.

3 . An isolated nucleic acid, encoding the chimeric DNA polymerase according to claim 1 .

4 . The isolated nucleic acid according to claim 3 , wherein the isolated nucleic acid has a nucleotide sequence set forth as SEQ ID NO: 2.

5 . A construct, comprising the isolated nucleic acid according to claim 3 .

6 . A recombinant cell or recombinant microorganism, containing the isolated nucleic acid according to claim 3 .

7 . A method for obtaining the chimeric DNA polymerase according to claim 1 , comprising:

culturing a recombinant cell or recombinant microorganism containing an isolated nucleic acid encoding the chimeric DNA polymerase under conditions suitable for expressing the chimeric DNA polymerase to obtain the chimeric DNA polymerase.

8 . A kit, containing the chimeric DNA polymerase according to claim 1 .

9 . The chimeric DNA polymerase according to claim 1 , wherein the chimeric DNA polymerase is used in DNA amplification, genetic screening, sequencing, or mutation detection.

10 . The isolated nucleic acid according to claim 3 , wherein the isolated nucleic acid is used in DNA amplification, genetic screening, sequencing, or mutation detection.

11 . The construct according to claim 5 , wherein the construct is used in DNA amplification, genetic screening, sequencing, or mutation detection.

12 . The recombinant cell or recombinant microorganism according to claim 6 , wherein the recombinant cell or recombinant microorganism is used in DNA amplification, genetic screening, sequencing, or mutation detection.

13 . The kit according to claim 8 , wherein the kit is used in DNA amplification, genetic screening, sequencing, or mutation detection.